Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis
Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed. Neurological complications of treatment have been documente...
Saved in:
| Main Authors: | Helen Defty, Edward Sames, Teresa Doherty, Rodney Hughes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Case Reports in Rheumatology |
| Online Access: | http://dx.doi.org/10.1155/2013/728371 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quality of life of patients with rheumatoid arthritis receiving etanercept
by: V N Amirdzanova, et al.
Published: (2009-08-01) -
Neurological Behcet’s disease with transverse myelitis in an adolescent: A case report
by: Jeanine McColl, et al.
Published: (2025-06-01) -
Etanercept In the treatment of AA-amyloidosis in juvenile rheumatoid arthritis
by: H Mihels
Published: (2004-08-01) -
Efficacy and safety of the biosimilar etanercept in the treatment of patients with rheumatoid arthritis and spondyloarthritis
by: B. G. Issayeva, et al.
Published: (2024-10-01) -
EFFICACY OF ETANERCEPT IN CHILD WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
by: T.M. Bzarova, et al.
Published: (2011-03-01)